Form 4: Tenet Healthcare EVP Thomas Arnst Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas Arnst, reports transactions involving common stock and restricted stock units.

Summary

  • Thomas Arnst, EVP, Chief Admin. Officer & GC of Tenet Healthcare Corp, reported transactions involving the company's common stock.
  • On February 23, 2024, Arnst acquired 4,213 shares of common stock through the vesting of restricted stock units and disposed of 1,658 shares to cover tax obligations at a price of $92.8.
  • Following these transactions, Arnst directly owned 27,456 shares of common stock.
  • On February 24, 2024, Arnst acquired 4,156 shares of common stock through the vesting of restricted stock units and disposed of 1,636 shares to cover tax obligations at a price of $92.8.
  • Arnst also disposed of 8,222 shares to satisfy withholding taxes due upon vesting of performance share units.
  • Following these transactions, Arnst directly owned 21,754 shares of common stock.
  • The reported transactions also involved the vesting of 2022 and 2021 restricted stock units, which convert into common stock on a one-for-one basis.
  • Chad J. Wiener, as Attorney-in-fact for Thomas W. Arnst, signed the report on February 27, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their trading activities and ownership positions in their companies.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates

DateDescription
02/24/2021Grant date of 2021 Restricted Stock Units
02/23/2022Grant date of 2022 Restricted Stock Units
02/23/2024Transaction date: vesting of restricted stock units and tax withholding
02/24/2024Transaction date: vesting of restricted stock units and tax withholding
02/27/2024Date of Form 4 signature

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.